Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways.
about
Lipoxins: nature's way to resolve inflammationLipoxinA4 attenuates myocardial ischemia reperfusion injury via a mechanism related to downregulation of GRP-78 and caspase-12 in ratsResolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytesNeuroprotective effects of lipoxin A4 in central nervous system pathologies.Selective inhibition of IFNG-induced autophagy by Mir155- and Mir31-responsive WNT5A and SHH signalingTargeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery.Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation.Lipoxin A4 Activates Nrf2 Pathway and Ameliorates Cell Damage in Cultured Cortical Astrocytes Exposed to Oxygen-Glucose Deprivation/Reperfusion Insults.Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosisAspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cellsLipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXRα signaling pathway in THP-1 macrophage-derived foam cells.Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney DiseaseResolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages.Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 PhagocytosisLipoxin A4 pretreatment mitigates skeletal muscle ischemia-reperfusion injury in rats.Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis.Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins.Targeting neutrophil apoptosis for enhancing the resolution of inflammation.Lipoxin A4 activates alveolar epithelial sodium channel gamma via the microRNA-21/PTEN/AKT pathway in lipopolysaccharide-induced inflammatory lung injury.Cigarette smoke extract-induced BEAS-2B cell apoptosis and anti-oxidative Nrf-2 up-regulation are mediated by ROS-stimulated p38 activation.Resolution of inflammation pathways in preeclampsia-a narrative review.Striking the right immunological balance prevents progression of tuberculosis.Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production.Role of lipoxin A4 in the cell-to-cell interaction between all-trans retinoic acid-treated acute promyelocytic leukemic cells and alveolar macrophages.Activation of autophagy in macrophages by pro-resolving lipid mediators.Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia.Lipoxin A4 selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression.Lipoxin A4 ameliorates cerebral ischaemia/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2.Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.Macrophage-Bacteria Interactions-A Lipid-Centric Relationship.Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II
P2860
Q26784376-959F4A9C-CC48-4B51-BAC2-285B26FCA2C6Q28567910-21AFCD2A-DBDE-4474-8A43-FED0F1BB9E0EQ29248096-B5057A0C-8E6E-4087-A258-CE64EDF62060Q30857083-16738C9E-696C-4D1E-AF9D-3D40B7DE0CF6Q33577564-73E49A74-959D-4321-BD34-22DA6A22DCADQ33695357-10D100C6-E648-44DD-90C8-47F2EF3AE512Q34263376-5B985214-816A-413C-9C88-737FEC9EB834Q34463944-B9D4FCF2-ED9E-4581-B0D1-641201DCB21BQ35163164-01590477-7753-43DC-B2CB-E286D86D2FBBQ35184153-710AAE10-64C4-4805-A9C8-5C0F633B33A8Q35919112-9EF9B225-70CD-4154-87BC-62BA1D2B7949Q36095550-9B647E68-A3E4-4FE4-A48B-EFD026EDF400Q36174560-21B6507A-13A3-4273-8AB2-CD82D551AE23Q36777563-7AAAE1E4-EBED-4109-AABD-83F33D05862AQ37732997-FC94106C-0F57-4C73-937D-63E72162BF7FQ37946729-23D4FA74-D5C0-49F3-AC4E-9FB77A3F4D9EQ38091028-D54905C1-573A-449B-8F12-742A1FE937B2Q38202818-8F1D956C-DAF5-4E84-B6FC-0E303A735E30Q38841318-64C7461A-FAF2-4AAF-ACB0-774430D34B51Q38964879-E12F24E6-1BC4-496A-8212-E630A99EA066Q39229350-8EB0BEE4-7919-4406-A131-52E17DD595D5Q39437320-B0133115-86ED-4C2B-B92C-5D6E558A88ABQ39527391-96428106-2A86-4277-A269-6375E56617D1Q39543639-241558AA-233B-4CE8-8288-5A516655D305Q39961845-50D44356-554C-4CFC-8C33-29A65CD20A98Q40539832-2A77C5D5-938D-41AA-B760-071EF791255EQ46468014-BE57EDCF-8F19-4A4E-B0DE-30A0780524EDQ47949882-FF6F9297-AEE0-4A49-B189-857DEFAE6364Q48484880-F5BF547E-6065-4A98-9CC6-DDD10F04AF39Q49165366-33366C98-AFE6-46A5-AE5A-9EAFDDC683DCQ56699408-2CC51968-F0A8-4441-8BAC-4224144261C8
P2860
Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Lipoxin A4 impairment of apopt ...... he ERK/Nrf-2 defense pathways.
@en
Lipoxin A4 impairment of apopt ...... he ERK/Nrf-2 defense pathways.
@nl
type
label
Lipoxin A4 impairment of apopt ...... he ERK/Nrf-2 defense pathways.
@en
Lipoxin A4 impairment of apopt ...... he ERK/Nrf-2 defense pathways.
@nl
prefLabel
Lipoxin A4 impairment of apopt ...... he ERK/Nrf-2 defense pathways.
@en
Lipoxin A4 impairment of apopt ...... he ERK/Nrf-2 defense pathways.
@nl
P2093
P2860
P356
P1476
Lipoxin A4 impairment of apopt ...... he ERK/Nrf-2 defense pathways.
@en
P2093
M Fernández-Velasco
P G Través
P Martín-Sanz
P2860
P2888
P304
P356
10.1038/CDD.2009.220
P577
2010-01-22T00:00:00Z